Detalhe da pesquisa
1.
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.
N Engl J Med
; 390(4): 326-337, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078508
2.
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial.
Blood
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643491
3.
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesions.
Nature
; 559(7713): 285-289, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973717
4.
Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(5): 535-552, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37142374
5.
International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome.
J Allergy Clin Immunol
; 149(1): 410-421.e7, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033842
6.
Obinutuzumab as consolidation after chemo-immunotherapy: Results of the UK National Cancer Research Institute phase II/III GALACTIC trial.
Br J Haematol
; 199(5): 707-719, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36017875
7.
SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study.
Clin Exp Immunol
; 207(1): 3-10, 2022 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020852
8.
Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL.
Blood
; 135(6): 411-428, 2020 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31794600
9.
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status.
Blood
; 130(2): 156-166, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495793
10.
UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high-dose chemoradiotherapy for patients with malignancy.
J Clin Apher
; 33(1): 46-59, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28631842
11.
Fatal systemic angiomatosis with widespread sclerotic skeletal changes, diagnosed with the aid of a bone marrow biopsy: the lymphatics enter the bone marrow.
Pol J Pathol
; 69(3): 314-318, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30509059
12.
Reduced-intensity conditioning allogeneic transplantation after salvage treatment with DT-PACE in myeloma patients relapsing early after autologous transplant.
Eur J Haematol
; 99(4): 300-305, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632322
13.
Imbruvica®â¾(ibrutinib) patient support programme for chronic lymphocytic leukaemia and mantle cell lymphoma.
Br J Nurs
; 26(10): S20-S25, 2017 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28541116
14.
COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.
Br J Haematol
; 194(3): 646-650, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028800
15.
COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium.
Br J Haematol
; 192(1): e11-e14, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151540
16.
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.
Br J Haematol
; 189(6): 1057-1058, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32369609
17.
COVID-19 in bone marrow transplant recipients: reflecting on a single centre experience.
Br J Haematol
; 190(2): e67-e70, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469077
18.
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Front Immunol
; 15: 1350470, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38629074
19.
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Blood Adv
; 8(5): 1209-1219, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127279
20.
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study.
EClinicalMedicine
; 62: 102131, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599908